Boston Scientific, US10117L1017

Boston Scientific stock slips before the bell after September 23 decline

Published on 09/24/2026 at 07:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 23, 2026, Boston Scientific stock traded lower as the S&P 500 fell 0.8 percent to 7,706.03. A same-day filing disclosed an executive retirement effective January 1, 2027.

Sterile Fertigungslinie für Herzkathetersysteme in einem Medizintechnik-Reinraum in Marlborough MA
Boston Scientific Corp. betreibt sterile Reinraumfertigung für Herzkathetersysteme am Standort Marlborough MA, ISIN US10117L1017, Illustration mit AI erstellt.

Boston Scientific stock closed at USD 43.15 on the NYSE on September 23, 2026, down 0.44 percent. The S&P 500 fell 0.8 percent to 7,706.03 in the same session, a 0.36 percentage point wider decline than Boston Scientific stock.

September 23, 2026 in numbers

Boston Scientific Corporation (ISIN US10117L1017, NYSE: BSX) traded between USD 42.72 and USD 43.15 on September 23, 2026, according to MarketBeat data. The stock volume was 1.02 million shares, while the reported 52-week range was USD 42.20 to USD 105.65.

As StockTitan reported on September 23, 2026, Executive Vice President Arthur C. Butcher plans to retire effective January 1, 2027, and remain as a senior advisor through February 26, 2027.

Today and the next reporting date

Boston Scientific stock enters the September 24, 2026, session with the next quarterly results scheduled for October 28, 2026, according to Yahoo Finance. The company-specific filing and the broader 0.8 percent S&P 500 decline are the dated developments available for the pre-market view.

Disclaimer...

en | US10117L1017 | BOSTON SCIENTIFIC | boerse | 70174192 | bgmi